Project Grant R01HL179656
Award Date
5/1/25
Completion Date
2/28/29
Dollars Obligated
$631K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $361,083.00 to investigate how the acetylation of the transcriptional cofactor YAP regulates its subcellular localization and impacts cardiac regeneration following myocardial infarction. The 5-year research project, awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, aims to elucidate the mechanisms by which...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support research into the Hippo-YAP signaling pathway and its role in cardiac regenerative repair. The $693,261 award, effective January 10, 2025 through December 31, 2028, aims to develop gene therapy strategies that can enhance cardiac function and promote regenerative responses following myocardial infarction. The research will...
This $586,599 federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to investigate the regulatory mechanisms by which autophagy, a cellular process that declines with age, ensures cytoprotective effects and contributes to hormetic stress responses. The award supports research at the Sanford Burnham Prebys Medical Discovery Institute to analyze the spatio-temporal requirement for the autophagy-regulating transcription factors HLH-30/TFEB...
This is a Project Grant award from the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The $107,948 award supports research to investigate the mechanism by which mitochondrial protein import stress can induce the release of beneficial myokines, which are signaling molecules produced by muscle cells. The 5-year project aims to uncover how this mitochondrial stress pathway activates myokine expression and determine if the induced myokines can promote...
This $1,039,863 National Institutes of Health National Institute on Aging project grant funds research at Harvard Medical School to reverse engineer the process of cellular senescence. The research will use new microscopy techniques to observe cell size changes and correlate protein expression and phosphorylation with senescence markers as cells transition from normal to senescent states in vitro and in vivo in young and aged mice. The same induction-maturation-death lifecycle will be studied...
This Project Grant award, valued at $1,419,308 and spanning from September 2024 to August 2025, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program. The award supports research to investigate the mechanisms linking persistent DNA damage to the upregulation of the NLRP12 gene, and the functional implications of this link in aging hematopoiesis. The research aims to establish a novel interplay between persistent DNA...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research on the role of chaperone-mediated autophagy (CMA) in cardiac fibrosis and infarct repair. The $785,198 grant awarded on May 1, 2025 will enable researchers at the Albert Einstein College of Medicine to study how CMA regulates fibroblast and myofibroblast function during cardiac remodeling following myocardial infarction....
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a comprehensive study on the role of mitochondrial function in aging-related diseases. The $2,010,291 award to The Johns Hopkins University will leverage genetic data, metabolomics, and proteomics from over 680,000 participants to identify novel biomarkers and causal relationships between mitochondrial dysfunction and conditions like all-cause mortality, cardiovascular disease, and frailty. By...
This $566,022 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research at Albert Einstein College of Medicine to investigate the mechanisms by which the sympathetic nervous system regulates the aging of hematopoietic stem cell niches. The research aims to define how neural signal transduction via connexin gap junctions and reactive oxygen species (ROS) homeostasis in mesenchymal...
This $256,310 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to determine the role of neonatal reactive oxygen species (ROS) in the maturation and injury response of cardiomyocytes. The primary goals are to (1) assess the necessity of neonatal ROS increase in establishing oxidative tolerance in cardiomyocytes prior to ischemic injury, and (2) investigate the role of ROS in driving the...